Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. DCOY
DCOY logo

DCOY

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

DCOY News

Decoy Therapeutics to Execute 1-for-12 Reverse Stock Split

5d agoseekingalpha

Decoy Therapeutics Announces 1-for-12 Reverse Stock Split

5d agoPRnewswire

Decoy Therapeutics to Participate in Corporate Connect Webinar

Feb 05 2026PRnewswire

Decoy Therapeutics Partners with Gates Foundation on Global Access Commitment

Feb 04 2026PRnewswire

Decoy Therapeutics Announces Global Access Commitment with Gates Foundation

Feb 04 2026Newsfilter

Roth Capital Initiates Buy Rating on vTv Therapeutics with $58 Price Target

Jan 23 2026Benzinga

Decoy Therapeutics Secures Gates Foundation Funding to Advance Global Manufacturing of Antivirals

Jan 13 2026PRnewswire